Juramt, N.; Zeleznik, O.A.; Pasquale, L.R.; Wiggs, J.L.; Kang, J.H.
Metabolomic Signatures and Predictive Utility of LOXL1-Associated Genetic Risk Scores for Exfoliation Syndrome/Glaucoma in US Cohorts. Metabolites 2025, 15, 582.
https://doi.org/10.3390/metabo15090582
AMA Style
Juramt N, Zeleznik OA, Pasquale LR, Wiggs JL, Kang JH.
Metabolomic Signatures and Predictive Utility of LOXL1-Associated Genetic Risk Scores for Exfoliation Syndrome/Glaucoma in US Cohorts. Metabolites. 2025; 15(9):582.
https://doi.org/10.3390/metabo15090582
Chicago/Turabian Style
Juramt, Namuunaa, Oana A. Zeleznik, Louis R. Pasquale, Janey L. Wiggs, and Jae H. Kang.
2025. "Metabolomic Signatures and Predictive Utility of LOXL1-Associated Genetic Risk Scores for Exfoliation Syndrome/Glaucoma in US Cohorts" Metabolites 15, no. 9: 582.
https://doi.org/10.3390/metabo15090582
APA Style
Juramt, N., Zeleznik, O. A., Pasquale, L. R., Wiggs, J. L., & Kang, J. H.
(2025). Metabolomic Signatures and Predictive Utility of LOXL1-Associated Genetic Risk Scores for Exfoliation Syndrome/Glaucoma in US Cohorts. Metabolites, 15(9), 582.
https://doi.org/10.3390/metabo15090582